Phase I/II study of brentuximab vedotin in pediatric patients (pts) with relapsed or refractory (RR) Hodgkin lymphoma (HL) or systemic anaplastic large-cell lymphoma (sALCL): Interim phase (ph) I safety data.
Kathleen Neville
No relevant relationships to disclose
Lia Gore
No relevant relationships to disclose
Christine Mauz-Körholz
No relevant relationships to disclose
Angelo Rosolen
No relevant relationships to disclose
Judith Landman-Parker
No relevant relationships to disclose
Jose Sanchez de Toledo
No relevant relationships to disclose
Auke Beishuizen
No relevant relationships to disclose
Anna Rachel Keating Franklin
Research Funding - Millennium
Adedigbo Fasanmade
Employment or Leadership Position - Millennium
Jingyuan Wang
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
Dirk Huebner
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
Franco Locatelli
No relevant relationships to disclose